This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Green D, Lechner K . A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200–203.
Stricker RB, Barlogie B, Kiprov DD . Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy. J Rheumatol 1994; 21: 350–352.
Levesque H, Borg JY, Bossi P et al. Acquired hemophilia: current diagnostic and therapeutic approaches. Rev Med Int 2001; 22: 854–866.
Fassas A, Anagnostopoulos A, Kazis A et al. Autologous stem cell transplantation in progressive multiple sclerosis – an interim analysis of efficacy. J Clin Immunol 2000; 20: 24–30.
Moake JL, Kent CJ, Meta LD, Wright LC . Circulating IgG antibodies against factors IX and VIII in multiple sclerosis. Acta Haematol 1976; 55: 53–59.
Hoyle C, Ludlam CA . Acquired factor VIII inhibitor associated with multiple sclerosis, successfully treated with porcine factor VIII. Thromb Haemost 1987; 57: 233.
Stricker RB, Barlogie B, Kiprov DD . Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy. J Rheumatol 1994; 21: 350–352.
English KE, Brien WF, Howson-Jan K, Kovacs MJ . Acquired factor VIII inhibitor in a patient with chronic myelogenous leukemia receiving interferon-alpha therapy. Ann Pharmacother 2000; 34: 737–739.
Ozenci V, Kouwenhoven M, Huang YM et al. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha) – and IL-10 secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin Exp Immunol 2000; 120: 147–153.
Reding MT, Lei S, Lei H et al. Distribution of Th1 and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Thromb Haemost 2002; 88: 568–575.
Toor AA, Slungaard A, Hedner U et al. Acquired factor VII deficiency in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2002; 29: 403–408.
Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A . Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003; 121: 21–35.
Wiestner A, Cho HJ, Asch AS et al. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002; 100: 3426–3428.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaloyannidis, P., Sakellari, I., Fassas, A. et al. Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a. Bone Marrow Transplant 34, 187–188 (2004). https://doi.org/10.1038/sj.bmt.1704550
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704550
This article is cited by
-
Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases
Pediatric Research (2012)